When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL.

Jonathan E Kaplan; Debra L Hanson; David L Cohn; John Karon; Susan Buskin; Melanie Thompson; Patricia Fleming; Mark S Dworkin; Adult and Adolescent Spectrum of HIV Disease Project Investigators

doi:10.1086/377606

When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL.

Identifier:nobleid.org/w1/20260515/137BDF52

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/137BDF52.svg?ark=w1%2F20260515%2F137BDF52)](https://nobleid.org/work/w1/20260515/137BDF52)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Adult and Adolescent Spectrum of HIV Disease Project Investigators

Claim authorship of this work

When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL.

Identifier:nobleid.org/w1/20260515/137BDF52

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/137BDF52.svg?ark=w1%2F20260515%2F137BDF52)](https://nobleid.org/work/w1/20260515/137BDF52)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Adult and Adolescent Spectrum of HIV Disease Project Investigators

Claim authorship of this work